ItamarTM Medical Announces Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include WatchPATTM in Their Policies

– CMS Announces 2020 Fee Schedule –

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep-apnea and uses a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the cardiology market, today announced that Blue Shield of California (BSC) and the Blue Cross Blue Shield Federal Employee Plan (BCBS FEP) have included WatchPATTM as a covered home sleep apnea diagnostic test. The home sleep testing company also announced the release of the U.S. Centers for Medicare & Medicaid Services (CMS) 2020 Fee Schedule which is the second year of a 3-year proposed plan by CMS to reevaluate reimbursement in home sleep apnea diagnostic codes. The changes made in the 2020 Fee Schedule are expected to continue to support and expand the broad use of its WatchPAT technology.